2012
DOI: 10.1684/ejd.2012.1640
|View full text |Cite
|
Sign up to set email alerts
|

Verrucous skin lesions on the feet in diabetic neuropathy successfully treated with topical maxacalcitol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Topical ointments containing agents such as sulfadiazine and salicylic acid, cryotherapy, electrocoagulation and surgical treatment were usually ineffective. Topical 5‐fluorouracil, tacalcitol, maxacalcitol and a hollowed‐out sponge have been tried and have shown favorable effects. However, the pathogenesis of VSLDN remains largely unknown.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Topical ointments containing agents such as sulfadiazine and salicylic acid, cryotherapy, electrocoagulation and surgical treatment were usually ineffective. Topical 5‐fluorouracil, tacalcitol, maxacalcitol and a hollowed‐out sponge have been tried and have shown favorable effects. However, the pathogenesis of VSLDN remains largely unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Verrucous skin lesions on the feet in diabetic neuropathy is categorized as a pseudoepitheliomatous hyperplasia that can be triggered by various chronic inflammatory stimuli on the background of diabetic neuropathy. There have been eight reports of VSLDN in the English‐language published work (Table ). According to the previous reports, VSLDN often developed on the hallux and sole, which are subjected to chronic focal pressure accompanied by sensory loss caused by intractable diabetes mellitus.…”
Section: Discussionmentioning
confidence: 99%
“…Rapid resolution of a case of recalcitrant, chronic verrucous lesions of diabetic neuropathy with 6 weeks of maxacalcitol ointment and epidermodysplasia after 8 months of tacalcitol has also been reported. 170,171 In conclusion, topical maxacalcitol applied under occlusion is a safe and effective therapeutic option for patients with recalcitrant warts, especially in pediatric or immunocompromised patients (Level 3a evidence).…”
Section: Verruca Vulgarismentioning
confidence: 98%